Turn the challenges of
today into the innovations
of tomorrow

ReCalibrate: where leading experts share
ideas and insights on the future
of diagnostic laboratories

The future of healthcare
–and labs– starts at home

A new opportunity to convert your health system lab from a cost center to a revenue driver.

To thrive tomorrow, laboratorians ReCalibrate their strategies today



of US consumers engage with healthcare providers via both digital and in-person healthcare-related activities.1




projected global market size of at-home diagnostic testing by 2025.2


Labs are creating new value for health systems by meeting consumers where they are in their lives and community.

What could your labs direct-to consumer service
look like?

Laboratorians weigh in on the possibilities in The Future of Healthcare—and Labs—Starts at Home.



Experts Talk Lab Innovation on ReCalibrate


ReCalibrate is a digital forum where leading experts in the lab industry and beyond share ideas and insights on the challenges laboratories face today and how to create growth for tomorrow.

Editor's Picks

How to survive—and thrive—in a historic workforce shortage

7 strategies for redefining your lab workforce

Mind Shift

It's time for laboratorians to start thinking like entepreneurs

"At the end of the day, innovation in the lab is going to be more about delivery and patient access than about the next test."

-Stan Schofield, Managing Principal, Compass Group

"Today, reinvention is less about technology and more about people and process."

-Jon Harol, Lighthouse Lab Services

"We've taken the approach that many businesses do, and we've diversified revenue sources. We've had to change, we had to bring that business acumen"

-Eric Carbonneau, COO, TriCore


Join the Conversation on the Future of Labs

Follow Abbott Diagnostics on LinkedIn to connect with leading experts and share your insights and innovations

1. Leventhal R. The Digital Healthcare Consumer 2023. Insider Intelligence. Published March 13, 2023. 
2. CNBC The at-home testing industry, from Covid to cancer, may be worth over $2 billion by 2025. Published February 3, 2022.